{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:01:10Z","timestamp":1783519270683,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.adro.2022.101011","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T02:13:14Z","timestamp":1656727994000},"page":"101011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1587-7951","authenticated-orcid":false,"given":"Elise","family":"Konradsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Liljedahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Adrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhayb Ehsaan","family":"Ilaahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crister","family":"Ceberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Nittby Redebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2022.101011_bib0001","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Eng J Med"},{"key":"10.1016\/j.adro.2022.101011_bib0002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-020-03451-6","article-title":"Trends in glioblastoma: outcomes over time and type of intervention: A systematic evidence based analysis","volume":"147","author":"Marenco-Hillembrand","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.adro.2022.101011_bib0003","first-page":"vdab008","article-title":"Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: To whom do the results of the trials apply?","volume":"3","author":"Skaga","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.adro.2022.101011_bib0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/neuros\/nyx115","article-title":"Stereotactic radiosurgery and hypofractionated radiotherapy for glioblastoma","volume":"82","author":"Shah","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.adro.2022.101011_bib0005","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3390\/cancers12092511","article-title":"Radioresistance in glioblastoma and the development of radiosensitizers","volume":"12","author":"Ali","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.adro.2022.101011_bib0006","doi-asserted-by":"crossref","first-page":"245ra93","DOI":"10.1126\/scitranslmed.3008973","article-title":"Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice","volume":"6","author":"Favaudon","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.adro.2022.101011_bib0007","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3389\/fonc.2019.01563","article-title":"Ultra-high dose rate (FLASH) radiotherapy: Silver bullet or fool's gold?","volume":"9","author":"Wilson","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1078-0432.CCR-17-3375","article-title":"The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients","volume":"25","author":"Vozenin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2022.101011_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.658004","article-title":"Establishment and initial experience of clinical FLASH radiotherapy in canine cancer patients","volume":"11","author":"Konradsson","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.radonc.2017.05.003","article-title":"Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy\/s","volume":"124","author":"Montay-Gruel","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0011","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1158\/1078-0432.CCR-20-0894","article-title":"Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice","volume":"27","author":"Montay-Gruel","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2022.101011_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2019.04.008","article-title":"Clinical translation of FLASH radiotherapy: Why and how?","volume":"139","author":"Bourhis","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0013","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cancers13051012","article-title":"FLASH proton pencil beam scanning irradiation minimizes radiation-induced leg contracture and skin toxicity in mice","volume":"13","author":"Cunningham","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.adro.2022.101011_bib0014","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2020.10.012","article-title":"Ultra-high-dose-rate FLASH and conventional-dose-rate irradiation differentially affect human acute lymphoblastic leukemia and normal hematopoiesis","volume":"109","author":"Chabi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101011_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijrobp.2019.10.049","article-title":"Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system","volume":"106","author":"Diffenderfer","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101011_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78017-7","article-title":"Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice","volume":"10","author":"Levy","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.adro.2022.101011_bib0017","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1667\/RADE-20-00067.1","article-title":"Ultra-high-dose-rate FLASH irradiation limits reactive gliosis in the brain","volume":"194","author":"Montay-Gruel","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.adro.2022.101011_bib0018","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1667\/RADE-20-00060.1","article-title":"Maintenance of tight junction integrity in the absence of vascular dilation in the brain of mice exposed to ultra-high-dose-rate FLASH irradiation","volume":"194","author":"Allen","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.adro.2022.101011_bib0019","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/cancers12061671","article-title":"Neuroprotection of radiosensitive juvenile mice by ultra-high dose rate FLASH irradiation","volume":"12","author":"Alaghband","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.adro.2022.101011_bib0020","first-page":"871","article-title":"Growth pattern of experimental glioblastoma","volume":"35","author":"Ahlstedt","year":"2020","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.adro.2022.101011_bib0021","first-page":"101","article-title":"A GFP positive glioblastoma cell line NS1 - A new tool for experimental studies","volume":"1","author":"Nittby","year":"2015","journal-title":"Brain Tumors Neurooncol"},{"key":"10.1016\/j.adro.2022.101011_bib0022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2019.01.031","article-title":"Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation","volume":"139","author":"Lempart","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/1559325817705019","article-title":"Radiotherapy-induced skin reactions induce fibrosis mediated by TGF-\u03b21 cytokine","volume":"15","author":"de Andrade","year":"2017","journal-title":"Dose Response"},{"key":"10.1016\/j.adro.2022.101011_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.686142","article-title":"Cancer cells can exhibit a sparing FLASH effect at low doses under normoxic in vitro conditions","volume":"11","author":"Adrian","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0025","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1667\/RADE-20-00090","article-title":"FLASH irradiation results in reduced severe skin toxicity compared to conventional-dose-rate irradiation","volume":"194","author":"Soto","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.adro.2022.101011_bib0026","doi-asserted-by":"crossref","unstructured":"Gaide O, Herrera F, Sozzi WJ, et al. Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma [e-pub ahead of print]. Radiother Oncol. 2022;174:87-91, accessed January 14, 2022.","DOI":"10.1016\/j.radonc.2021.12.045"},{"key":"10.1016\/j.adro.2022.101011_bib0027","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2021.12.022","article-title":"In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH","volume":"167","author":"Singers S\u00f8rensen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0028","unstructured":"Brus Anja, et al. Comparison of the anti-tumor effect and immuno-biological response in the tumor microenvironment after FLASH or conventional electron irradiation. 2022. [Manuscript in preparation]"},{"key":"10.1016\/j.adro.2022.101011_bib0029","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190702","article-title":"The FLASH effect depends on oxygen concentration","volume":"93","author":"Adrian","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2022.101011_bib0030","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/stem.3391","article-title":"Radiotherapy and the immune system: More than just immune suppression","volume":"39","author":"R\u00fcckert","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/j.adro.2022.101011_bib0031","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2020.04.054","article-title":"Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?","volume":"149","author":"Jin","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101011_bib0032","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.040386","article-title":"Experimental models and tools to tackle glioblastoma","volume":"12","author":"Robertson","year":"2019","journal-title":"Dis Model Mech"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:42:00Z","timestamp":1762530120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109422001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2452109422001178"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2022.101011","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2022.101011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101011"}}